Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomized controlled trial - Samson, S L; Sathyanarayana, P; Jogi, M (Diabetologia, 2011)
et al.